Attached files

file filename
8-K/A - WAXESS FORM 8-K/A 02/03/11 - AirTouch Communications, Inc.waxessform8ka020311.htm


Exhibit 99.4






FINANCIAL STATEMENTS

For the Years Ended December 31, 2010 and 2009



 
1

 

 
WAXESS USA, INC.
 
TABLE OF CONTENTS
 
FOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009

 



Report of Independent Registered Public Accounting Firm
3
Balance Sheets as of December 31, 2010 and 2009
4
Statements of Operations for the years ended December 31, 2010 and 2009
5
Statements of Stockholders’ Deficit for the years ended December 31, 2010 and 2009
6
Statements of Cash Flows for the years ended December 31, 2010 and 2009
7
Notes to Financial Statements
8

 
2

 


REPORT OF INDEPENDENT REGISTERED ACCOUNTING FIRM


The Board of Directors and Stockholders’ of Waxess USA, Inc.:

 
We have audited the accompanying balance sheets of Waxess USA, Inc. (the “Company”) as of December 31, 2010 and 2009, and the related statements of operations, stockholders’ deficit, and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States of America). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Waxess USA, Inc. as of December 31, 2010 and 2009, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has a loss from operations and an accumulated deficit of $6,686,796 at December 31, 2010. As discussed in Note 10 to the financial statements, a significant amount of additional capital will be necessary to advance operations to the point at which Company is profitable. These conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are described in Note 10. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 
 
/s/ Anton & Chia, LLP

Newport Beach, California
March 28, 2011

 
3

 
WAXESS USA, INC.
BALANCE SHEETS
AS OF DECEMBER 31, 2010 AND 2009



ASSETS
 
   
2010
   
2009
 
Current assets
           
Cash
  $ 201,299     $ 36,505  
Inventory
    329,118       -  
Prepaid expenses
    1,000       -  
Deferred financing costs
    46,400       -  
Total current assets
    577,817       36,505  
                 
Deposits
    23,394       -  
                 
Equipment, net
    155,847       119,800  
                 
Patents, net
    183,228       186,327  
                 
Total assets
  $ 940,286     $ 342,632  
                 
LIABILITIES & STOCKHOLDERS' DEFICIT
 
Current liabilities
               
Accounts payable
  $ 390,618     $ -  
Accrued expenses
    576,442       238,879  
Current portion of capital lease obligation
    6,181       -  
Notes payable-related party
    -       351,562  
Notes payable
    94,500       -  
Convertible notes payable
    3,035,000       530,000  
Derivative liability
    55,413       -  
Total current liabilities
    4,158,154       1,120,441  
                 
Capital lease obligation, net of current portion
    8,328       -  
                 
Total liabilities
    4,166,482       1,120,441  
                 
Stockholders’ deficit
               
Common stock, 10,000,000 shares authorized,
no par value, 5,934,704 and 4,465,167 shares issued and
outstanding as of December 31, 2010 and 2009, respectively
    -       -  
Additional paid-in capital
    3,460,600       1,058,612  
Accumulated deficit
    (6,686,796 )     (1,836,421 )
Total stockholders' deficit
    (3,226,196 )     (777,809 )
                 
Total liabilities and stockholders' deficit
  $ 940,286     $ 342,632  


The accompanying notes are an integral part of these financial statements.
 
 
4

 
WAXESS USA, INC.
STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009



   
2010
   
2009
 
             
Net revenue
  $ 160,441     $ 147,661  
                 
Cost of sales
    328,036       116,886  
Gross profit (loss)
    (167,595 )     30,775  
                 
Operating expenses
               
Research and development
    1,803,809       79,084  
Selling, general, and administrative
    2,162,700       914,272  
     Total operating expenses
    3,966,509       993,356  
                 
                 
Net loss from operations
    (4,134,104 )     (962,581 )
                 
Other expense
               
Interest expense
    427,301       63,370  
Other expense, net
    288,970       -  
     Total other expense, net
    716,271       63,370  
                 
Net loss
  $ (4,850,375 )   $ (1,025,951 )
                 
                 
Loss per share-basic and diluted
  $ (0.98 )   $ (0.24 )
                 
Weighted average common shares outstanding
    4,969,617       4,329,714  


The accompanying notes are an integral part of these financial statements.
 
 
5

 
WAXESS USA, INC.
STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
FOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009


 
 
   
Common stock
             
   
Shares
   
Amount
     
Additional 
paid in capital
     
Accumulated
deficit
   
Total
 
Balance at December 31, 2008
    4,117,960     $ -       412       (810,470 )     (810,058 )
                                         
Conversion of convertible note into common stock     173,836       -       503,474       -       503,474  
Sale of common stock
    78,572       -       249,980       -       249,980  
Issuance of common stock for service provided
    94,799       -       304,746       -       304,746  
Net loss
                            (1,025,951 )     (1,025,951 )
Balance at December 31, 2009
    4,465,167       -       1,058,612       (1,836,421 )     (777,809 )
                                         
Sale of common stock
    774,557       -       1,400,056       -       1,400,056  
Issuance of common stock in lieu of interest
    1,704       -       5,964       -       5,964  
Cancelled common stock
    (71,430 )     -       (7 )     -       (7 )
Conversion of debt, including accrued interest, into common stock
    764,706       -       995,975       -       995,975  
Net loss
                            (4,850,375 )     (4,850,375 )
Balance at December 31, 2010
    5,934,704     $ -       3,460,600       (6,686,796 )     (3,226,196 )
 
The accompanying notes are an integral part of these financial statements.
 
 
6

 
WAXESS USA, INC.
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009


   
2010
   
2009
 
Operating Activities:
           
Net loss
  $ (4,850,375 )   $ (1,025,951 )
Adjustments to reconcile net loss to net cash used in
               
        operating activities
               
Depreciation and amortization
    84,599       115,893  
Conversion of accrued interest into common stock
    26,877       -  
Write down of inventory
    167,081       -  
Gain on cancellation of debt
    (227,231 )     -  
Stock based compensation
    243,500       304,746  
Changes in operating assets and liabilities
               
Inventory
    (496,199 )     -  
Deferred financing costs
    (46,400 )     -  
Deposit and prepaid expenses
    (24,394 )     -  
Accounts payable
    485,188       (201,390 )
Accrued expenses
    564,678       34,626  
Net cash used in operating activities
    (4,072,676 )     (772,076 )
                 
Investing Activities:
               
Investment in patents
    (18,322 )     (16,639 )
Purchases of equipment
    (76,268 )     (5,800 )
  Net cash used in investing activities
    (94,590 )     (22,439 )
                 
Financing Activities:
               
Proceeds from the sale of bridge notes
    3,035,000       -  
Proceeds from the sale of common stock
    1,400,056       249,980  
Proceeds (payments) from convertible notes payable
    (30,000 )     530,000  
Payments on lease obligation
    (8,409 )     -  
Proceeds (payments) on notes payable – related party
    (120,000 )     35,551  
Derivative liability
    55,413       -  
  Net cash provided by financing activities
    4,332,060       815,531  
                 
Net increase in cash
    164,794       21,016  
                 
Cash at beginning of period
    36,505       15,489  
                 
Cash at end of period
  $ 201,299     $ 36,505  
                 
Supplemental disclosure of cash flow information
               
Cash paid for interest
  $ 2,410     $ 90,000  
                 
Supplemental disclosure of non-cash financing transactions
               
Conversion of debt, including accrued interest, into common stock
  $ 995,975     $ 503,474  
Issuance of common stock in lieu of interest payments
  $ 5,964     $ -  
Purchase of equipment by capital lease
  $ 22,956     $ -  
Conversion of accounts payable to notes payable
  $ 94,500     $ -  


The accompanying notes are an integral part of these financial statements.
 
 
7

 
NOTES TO FINANCIAL STATEMENTS


1.  ORGANIZATION AND BUSINESS
 
Waxess USA, Inc. (the “Company” or “Waxess”) was incorporated on February 4, 2008 under the laws of the state of California and, on the date of incorporation, certain assets from Waxess, Inc. a Delaware company, were transferred to the Company. Waxess USA, Inc. and Waxess, Inc. are related parties as defined by generally accepted accounting principles.  Waxess USA, Inc. is engaged in the development and marketing of telecommunication devices capable of converging traditional landline, cellular and data services based on patented technology.  The Company designs and markets a dual mode communication terminal (“DMCT”) under the name cell@homeTM, which is a wireless (cellular) and PSTN (landline) communications device for the home and small office. 
 
As discussed more fully in Note 16, the Company was merged into Waxess Holdings, Inc. on February 4, 2011.
 
2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Basis of Presentation
 
The accompanying financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America.

Use of Estimates

Financial statements prepared in accordance with accounting principles generally accepted in the United States require management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash equivalents are comprised of certain highly liquid investments with maturities of three months or less when purchased.  The Company maintains its cash in bank deposit accounts which at times may exceed federally insured limits.  The Company had no cash equivalents as of December 31, 2010 and 2009.

Accounts Receivable

Accounts receivable consists of trade accounts arising in the normal course of business. No interest is charged on past due accounts.  Accounts for which no payments have been received after 30 days are considered delinquent and customary collection efforts are initiated.  Accounts receivable are carried at original invoice amount less a reserve made for doubtful receivables based on a review of all outstanding amounts on a monthly basis.  Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition and credit history, and current economic conditions.  Accounts receivable are written off when deemed uncollectible.  Recoveries of accounts receivable previously written off are recorded when received.  There were no accounts receivable at December 31, 2010 and 2009.

 
8

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


Inventory

Inventory is stated at lower of cost or market on a first-in, first-out basis. Inventory consists of purchased finished goods and parts used by the contract manufacturer.

Equipment

Equipment is stated at cost. Major improvements and betterments are capitalized. Maintenance and repairs are expensed as incurred. Equipment is depreciated over five years. Depreciation is computed using the straight-line method for financial reporting purposes for income tax purposes. Depreciation expense for the years ended December 31, 2010 and 2009 was $63,178 and $93,000, respectively. Tooling equipment is purchased for use by the contract manufacturer and the contract firm performing research and development services.

Patents

Patents consist of legal costs associated with filing and maintaining patent applications.  The Company accounts for patents in accordance with ASC 350-30 and ASC 360. The Company amortizes the capitalized patent costs on a straight-line basis over a period of 10 years, management’s estimated useful life of the patents.

Long-Lived Assets

In accordance with ASC 350-30, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. The Company’s management currently believes there is no impairment of its long-lived assets. There can be no assurance, however, that market conditions will not change or demand for the Company’s products under development will continue. Either of these could result in future impairment of long-lived assets.

Fair Value of Financial Instruments

The fair value accounting guidance defines fair value as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.”  The definition is based on an exit price rather than an entry price, regardless of whether the entity plans to hold or sell the asset.  This guidance also establishes a fair value hierarchy to prioritize inputs used in measuring fair value as follows:
 
·  
Level 1:  Observable inputs such as quoted prices in active markets;  

·  
Level 2:  Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and  

·  
Level 3:  Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.  

 
9

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


Financial Instruments
 
The estimated fair values of our financial assets and liabilities that are recognized at fair value on a recurring basis, using available market information and other observable data are as follows:


   
December 31, 2010
   
December 31, 2009
 
   
Level 1
   
Level 2
   
Level 3
   
Total
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                                                 
   
Quoted
Prices in
Active
Markets or Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant Unobservable Inputs
         
Quoted
Prices in
Active
Markets or Identical
Assets
   
Significant
Other
Observable Inputs
   
Significant Unobservable Inputs
       
                                                 
Assets:
                                               
 Cash
  $ 201,299     $ -     $ -     $ 201,299     $ 36,505     $ -     $ -     $ 36,505  
 Total assets:
  $ 201,299     $ -     $ -     $ 201,299     $ 36,505     $ -     $ -     $ 36,505  
                                                                 
Liabilities:
                                                               
  Derivative liability
  $ -     $ -     $ 55,413     $ 55,413     $ -     $ -     $ -     $ -  
  Total liabilities:
  $ -     $ -     $ 55,413     $ 55,413     $ -     $ -     $ -     $ -  
                                                                 



 
10

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


Revenue Recognition

Revenues are derived from the sale of product purchased from a contract manufacturer.  The Company recognizes revenue on arrangements in accordance with FASB ASC No. 605, “Revenue Recognition”. In all cases, revenue is recognized when all of the following conditions exist: (a) persuasive evidence of an arrangement exists in the form of an accepted purchase order or equivalent documentation; (b) delivery has occurred, based on shipping terms, or services have been provided; (c) the Company’s price to the buyer is fixed or determinable, as documented on the accepted purchase order or similar documentation; and (d) collectability is reasonably assured. In 2010, two customers returned $151,745 of the Company’s products for software modifications due to changes by certain carriers.

Research and Development Costs

Research and development costs consist of expenditures for the research and development of new products and technology related to the Company’s products. The Company expenses all costs associated with research and development. Research and development costs for December 31, 2010 and 2009 totaled $1,803,809 and $79,084, respectively.

Advertising Costs

Advertising costs are expensed as incurred. Advertising and promotional expense for December 31, 2010 and 2009 totaled approximately $9,891 and $650, respectively, and are included in selling, general and administrative expense in the accompanying statements of operations.

Shipping and Handling Costs

Shipping and handling costs are charged to operations when incurred and are included in selling, general, and administrative expenses in the accompanying statements of operations. Shipping and other related costs for December 31, 2010 and 2009 totaled approximately $16,000 and $2,148, respectively.

Income Taxes

Deferred tax assets and liabilities are recorded based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.

The Company calculates a provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized by identifying the temporary differences arising from the different treatment of items for tax and accounting purposes. In determining the future tax consequences of events that have been recognized in the financial statements or tax returns, judgment and interpretation of statutes is required. Additionally, the Company uses tax planning strategies as a part of its tax compliance program. Judgments and interpretation of statutes are inherent in this process.

Loss per Share

Basic loss per share is computed by dividing earnings to common stockholders by the weighted average number of common shares outstanding (including shares reserved for issuance) during
 

 
11

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


the period. Diluted loss per share includes potentially dilutive securities such as warrants using various methods such as the treasury stock or modified treasury stock method in the determination of dilutive shares outstanding during each reporting period. The equity instruments attached to the convertible notes were not included in the earnings per share calculations because the inclusion would have been anti-dilutive.

Recent Accounting Pronouncements

Accounting standards promulgated by the FASB change periodically. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments.

In January 2010, FASB issued ASU No. 2010-01- Accounting for Distributions to Shareholders with Components of Stock and Cash. The amendments in this update clarify that the stock portion of a distribution to shareholders that allows them to elect to receive cash or stock with a potential limitation on the total amount of cash that all shareholders can elect to receive in the aggregate is considered a share issuance that is reflected in EPS prospectively and is not a stock dividend for purposes of applying Topics 505 and 260 (Equity and Earnings Per Share). The amendments in this update are effective for interim and annual periods ending on or after December 15, 2009, and should be applied on a retrospective basis. The Company has determined that the adoption of this ASU will not have a material impact on its financial statements.

In January 2010, the FASB issued ASU 2010-06, Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures about Fair Value Measurements (“ASU 2010-06”).  ASU 2010-06 requires new disclosures regarding transfers in and out of the Level 1 and 2 and activity within Level 3 fair value measurements and clarifies existing disclosures of inputs and valuation techniques for Level 2 and 3 fair value measurements.  The new disclosures and clarifications of existing disclosures are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosure of activity within Level 3 fair value measurements, which is effective for fiscal years beginning after December 15, 2010.  The Company has adopted of the expanded disclosure requirements of ASU 2010-06 and determined there is no material effect on its financial statements or prior year disclosures.
 
3.  CONCENTRATIONS
 
During the year 2010, the Company derived 36% of its revenue each from two customers and 12% of its revenue from one customer.  There were no outstanding receivables from these customers at December 31, 2010.

During 2010, approximately 86% of the Company’s purchases included in cost of sales were from one supplier.  There were no amounts outstanding to this supplier at December 31, 2010.

The Company had revenues from one customer during 2009 that accounted for 89% of the Company’s total net revenue.  There was no outstanding receivable from this customer at December 31, 2009.

During 2009, 97% of the cost of sales for the Company was from one supplier.  There was no amount outstanding to this supplier at December 31, 2009.

 
12

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


4.  IINVENTORY

Inventories consist of the following as of December 31, 2010, and 2009:
 
     
2010
   
2009
 
 
Finished Goods
  $ 254,118     $ -  
 
Parts
    75,000       -  
 
Total
  $ 329,118     $ -  


During 2010, the Company wrote down approximately $167,000 of its first generation inventory in anticipation of the introduction of its second generation product line.

There was no inventory at December 31, 2009.

5.  EQUIPMENT, NET

Equipment consists of the following as of December 31:
 
     
2010
   
2009
 
 
Tooling costs
  $ 351,800     $ 298,800  
 
Office furniture
    22,956       -  
 
Computers and equipment
    23,269       -  
 
Less: Accumulated depreciation
    (242,178 )     (179,000 )
 
Total Equipment, net
  $ 155,847     $ 119,800  


6.  PATENTS, NET

Amortization expense relating to the patents as of December 31, 2010 and 2009 totaled $21,421 and $22,893, respectively.  Future amortization expense for these assets is as follows.
 
 
2010
  $ 19,903  
 
2011
    19,692  
 
2012
    19,692  
 
2013
    19,692  
 
2014
    19,692  
 
Thereafter
    84,557  
 
Total
  $ 183,228  

 
13

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


7.  NOTES PAYABLE

On December 30, 2010, the Company converted an outstanding account payable in the amount of $94,500 to a note payable.  The note earns interest at a rate of 5.25% per annum and is due on July 1, 2011.  Interest only payments are due on the first of each month.
 
8.  BRIDGE LOANS
 
During the year ended December 31, 2010, the Company sold $3,035,000 of convertible notes to private investors (“Bridge Facility”).  The notes were sold in various amounts with a term of six months and a stated rate of interest of 10% compounded annually.  The notes provide for warrants to purchase common stock with a three year expiration.  As of December 31, 2010, holders of $2,735,000 of these notes agreed to extend the terms of the notes to the earlier of six months from the maturity date of the original note or the closing of a debt or equity financing with a minimum of $2 million in gross proceeds (“Financing Event”), and to convert their notes into common stock  equal to the amount of the note plus accrued interest divided by the lower of the stock price  as determined by the closing of the Financing Event  or 100% of the fair market value of the common stock at the date of the note.  In exchange for their agreement to extend the term of the note and to convert the note into equity the note holders received twice the amount of warrants provided under their original note and warrant agreement.  Holders of the remaining $300,000 in notes will be paid with the proceeds following the closing of the Financing Event.  As of December 31, 2010 there were warrants outstanding from the sale of convertible notes that could be converted into 2,985,000 shares of common stock. The note holders have a first priority interest in the assets of the Company.

During 2009, the Company issued a convertible note payable to a Corporation (Holder) with a principal amount of $500,000, earning interest at a rate of 7% per annum compounded quarterly.  All unpaid principal and interest was due and payable in two installments. One $250,000 installment was due on June 27, 2010, and the second installment of $250,000 was due on August 3, 2010.  According to the agreement, the holder is to receive 50,000 common shares.  In the event of the closing by the Company of a “Qualified Financing” prior to the maturity date, the Holder had the option to convert all or any portion of the outstanding principal of, and accrued interest on, this Note on a dollar-for-dollar basis into the shares of preferred stock being issued and sold to the investors in the Qualified Financing at a conversion price equal to 100% of the purchase price per share of the Qualified Financing paid by the investors in the Qualified Financing.  The note agreement defined a Qualified Financing as the closing of an equity investment in the form of the Company’s preferred stock occurring after the date hereof in which the Company receives from one or more investors (which investors may include the Holder) gross proceeds of at least $5,000,000.  During 2010, this note and all accrued interest was converted into common stock of the Company.  See Note 13.
 
9.  DERIVATIVE LIABILITY
 
As described in Note 8, during 2010, the Company issued financial instruments in the form of warrants and convertible notes payable with conversion features; granted warrants to purchase 120,250 shares of common stock to service providers; and granted a warrant in connection with entering into an agreement with Brightpoint, Inc. (see Note 13).  One of the terms of the agreement with Brightpoint provides that the Company grant a warrant to Brightpoint equal to 19.9% of the common stock of the Company on a fully-diluted basis following the closing of a

 
14

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


“Future Financing.”  A Future Financing is defined in the agreement as the Company selling shares of its common stock with gross proceeds of at least $5 million.  At December 31, 2010, the Company had not completed a Future Financing and no warrant had been granted to Brightpoint.
 
The conversion features of both the convertible notes payable and warrants meet the definition of a derivative liability due to the contract obligations.  Derivative instruments shall also be measured at fair value at each reporting period with gains and losses recognized in current earnings.  The Company calculated the fair value of these instruments using the Black-Scholes pricing model. The Company will adopt a binomial method in the first quarter of 2011. The significant assumptions used in the calculation of the instruments fair value are detailed in the table below.  

Derivative Liability – Warrants

As of December 31, 2010, the Company recorded a derivative liability of $55,413 for the issuance of warrants.  During the year ended December 31, 2010, the Company did not recognize a gain or loss based on the fair value mark-to-market adjustment of the derivative liability associated with the warrants in the accompanying statement of operations.  

These derivative liabilities have been measured in accordance with fair value measurements, as defined by GAAP.  The valuation assumptions are classified within Level 2 inputs and Level 3 inputs.  The following table represents the Company’s derivative liability activity for both the embedded conversion features and the warrants at December 31, 2010:


 
Issuance of derivative financial instrument
  $ 55,413  
 
Mark-to-market adjustment to fair value at December 31, 2010
    -  
 
Total
  $ 55,413  

The following assumptions were used to determine the fair value of the warrants as of December 31, 2010 and at date of issuance on March 15, 2010 through December 31, 2010:

 
Volatility
 
30%
 
 
Expected dividend
 
-
 
 
Expected term
 
 6 months to 3 years
 
 
Risk free rate
 
0.2%
 
 
Strike Price
 
$2.00
 


10.  CAPITAL LEASE

The Company is the lessee of office furniture under a capital lease expiring in February 2013.  The assets and liabilities held under capital lease are initially recorded at the lower of the present value of the minimum lease payments or the fair value of the asset.

 
15

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


The assets are depreciated over the lower of the related lease terms or their estimated productive lives.  Depreciation of assets under capital lease is included in depreciation expense for the year ended December 31, 2010.

The following is a summary of property and equipment held under capital lease:


 
Office Furniture
  $ 22,956  
 
Less: Accumulated Depreciation
    (4,591 )
 
Property Held Under Capital Lease, net
  $ 18,365  


Depreciation of assets held under this capital lease for the year ended December 31, 2010 was $4,591. The implicit interest rate under this capital lease is 35 percent.

Minimum future lease payments under this capital lease as of December 31, 2010, for each of the next 26 months and in the aggregate are as follows:


 
2011
  $ 9,714  
 
2012
    9,714  
 
2013
    31  
 
Total Minimum Lease Payments
    19,459  
 
Less: Amount Representing Interest
    (4,950 )
 
Present Value of Obligations Under Capital Lease
    14,509  
 
Less: Current Portion of Obligations Under Capital Lease
    (6,181 )
 
Long-Term Portion of Obligations Under Capital Lease
  $ 8,328  


11.  COMMITMENTS AND CONTINGINCIES
 
During the ordinary course of business, the Company encounters various legal claims which, in the opinion of management, will not materially affect the Company.
 
 
The Company leases office space in California under an operating lease. The Company signed a twenty five month lease beginning on May 17, 2010 through June 17, 2012. The Company is required to pay monthly rental payments of approximately $4,200. Total rent expense for the year ended December 31, 2010 totaled approximately $29,600. Future minimum payments are as follows:
 
 
2011
  $ 50,400  
 
2012
    25,200  
 
Total Minimum Lease Payments
  $ 75,600  

 
16

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


12.  RELATED PARTY TRANSACTIONS
 
On March 31, 2010, $227,376 of unpaid salary was forgiven by its Chief Executive Officer, which is included in other income in the statement of operations for the year ended December 31, 2010.  The unpaid salary was bearing interest at 11.25 % per annum.  Unpaid interest on accrued salaries to the Chief Executive Officer amounted to $22,978 for the year ended December 31, 2009.

The Company had loans payable to a company owned by the Chief Executive Officer in the amount of $217,166 as of December 31, 2009. This loan included interest of 11.25 %, did not include a prepayment penalty and was unsecured. Unpaid interest on the loan amounted to $21,960 for the year ended December 31, 2009.  The loan was converted to common stock during 2010.  See Note 13.
 
13.  STOCKHOLDERS’ TRANSACTIONS
 
Common Stock

During 2010, the Company sold 774,557 shares of common stock for $1,400,056.

During 2010, the Company cancelled 71,430 shares of common stock from two shareholders after using best efforts to make contact with them.

During 2010, related party notes in the amount of $231,562 were cancelled in exchange for 475,063 shares of common stock. The Company recognized $243,501 of expense for the difference between the carrying amount of the debt extinguished and the fair value of the stock issued and is included in selling, general and administrative expense in the statement of operations.
 
During 2010, the Company entered into certain agreements (“Agreements”) with Brightpoint, Inc.  The Agreements appoints Brightpoint as the master distributor for all of the Company’s products.  The exclusivity or non-exclusivity of the appointment is determined on a territory by territory basis.  The Agreements also provided for the sale of 787,186 shares of common stock to Brightpoint, Inc. for $1,500,000.  As of December 31, 2010, Brightpoint had purchased 715,800 shares of common stock.
 
 
During 2010, $500,000 of convertible notes payable and $20,913 of accrued interest was converted into 289,643 shares of the Company’s common stock.
 
During 2009, the Company sold 78,572 shares of common stock for $249,980.

During 2009, a note payable in the amount of $503,474 was converted into common stock. The note holder received 173,836 common shares in exchange for the conversion of this note payable. The holder of this note also received 44,799 shares of common stock in lieu of commissions earned for services performed for the Company.

During 2009, the Company issued 50,000 shares of common stock for services performed by an individual for a total value of $174,997.

 
17

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


14.  INCOME TAXES
 
The items accounting for the difference between income taxes computed at the federal statutory rate and the benefit for income taxes were as follows:


 
For the Year Ended December 31
 
2010
2009
Federal Statutory Rate
34.00%
34.00%
State Tax, Net of Federal Benefit
9.00%
9.00%
Valuation Allowance
(43.00%)
(43.00%)
Effective Income Tax Rate
   0.00%
 0.00%

Significant components of deferred tax assets and (liabilities) using the Company’s effective tax rates are as follows:

 
 
For the Year Ended December 31
 
2010
2009
Loss Carry forwards
$6,477,773
$1,603,982
Less – Valuation Allowance
(6,477,773)
(1,603,982)
State Tax, Net of Federal Benefit
$            -
$            -


The Company periodically evaluates the likelihood of the realization of deferred tax assets, and adjusts the carrying amount of the deferred tax assets by a valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not.  The Company considers many factors when assessing the likelihood of future realization of our deferred tax assets, including recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carry-forward periods available to us for tax reporting purposes, and other relevant factors.

At December 31, 2010, based on the weight of available evidence, including cumulative losses in recent years and expectations of future taxable income, the Company determined that it was more likely than not that its deferred tax assets would not be realized.  Accordingly, the Company has recorded a valuation allowance equivalent to 100% of its cumulative deferred tax assets.
 
As a result of the implementation of certain provisions of ASC 740 the Company performed an analysis of its previous tax filings and determined that there were no positions taken that it considered uncertain. Therefore, there was no provision for uncertain tax positions for the years ended December 31, 2010 and 2009.  Future changes in uncertain tax positions are not expected to have an impact on the effective tax rate due to the existence of the valuation allowance.
 

 
18

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


The Company will continue to classify income tax penalties and interest, if any, as part of interest and other expenses in its statements of operations. The Company has incurred no interest or penalties as of December 31, 2010 and 2009.
 
The following table summarizes the open tax years for each major jurisdiction:

Jurisdiction       Open Tax Years

Federal              2008 – 2010

State                   2008 – 2010

 
15.  GOING CONCERN
 
 
The Company sustained operating losses during the years December 31, 2010 and 2009.  Additionally, the Company has a stockholders’ deficit of $3,226,196 at December 31, 2010. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations and/or obtaining additional financing from its members or other sources, as may be required.
 
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.
 
In 2011, Management plans are to obtain additional contracts from customers to improve profitability and raise additional capital to build the infrastructure to support the growth of the Company.
 
16.  SUBSEQUENT EVENTS
 
In preparing these financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through March 28, 2011, the date the financial statements were issued.

During 2011, the Company sold $387,500 of convertible notes to private investors.  The notes were sold in various amounts with a term of six months and a stated rate of interest of 10% compounded annually.  The notes include a provision giving the note holders a warrant, with a three year expiration, to purchase common stock in an amount equivalent to the amount of the note divided by the lower of the stock price as determined by the closing of a debt or equity financing with a minimum of $2 million in gross proceeds (“Financing Event”) or 100% of the fair market value of the common stock at the date of the note.  The note holders have a first priority interest in the assets of the Company.
 
In 2011, the Company sold 171,386 shares of common stock for $250,000 in connection with the Agreement with Brightpoint, Inc. See Note 13.

 
19

 
WAXESS USA, INC.
NOTES TO FINANCIAL STATEMENTS


On February 4, 2011, the Company entered into an Agreement of Merger and Plan of Reorganization (the “Merger Agreement”) with Waxess Acquisition Corp., a wholly owned Delaware subsidiary of Waxess Holdings, Inc., formerly International Vineyard, Inc., and a publicly held Delaware shell corporation with no operations. Upon closing of the transaction (the “Merger”) contemplated under the Merger Agreement, the Company, the surviving corporation in the merger with Waxess Acquisition Corp., became a wholly-owned subsidiary of Waxess Holdings, Inc.  Pursuant to the terms and conditions of the Merger Agreement:
 
·  
At the closing of the Merger, each share of Waxess USA’s common stock issued and outstanding immediately prior to the closing of the Merger was exchanged for the right to receive 1.19883186 shares of our common stock. To the extent that there are fractional shares, such fractional shares will be rounded to the nearest whole share. Accordingly, an aggregate of 7,500,000 shares of our common stock were issued to the holders of Waxess USA’s common stock and represents approximately 87% of the outstanding shares of Waxess Holdings, Inc.
 
 
·  
In connection with the Merger, 1,083,333 shares of common stock held by persons who were stockholders of Waxess Holdings, Inc. prior to the Merger remaining outstanding. These 1,083,333 shares constitute the “public float” and are the only shares of registered common stock and accordingly are the only shares available for resale without further registration.
 

 20